- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01116349
Conservative Treatment Versus the Surgical Treatment of Diaphyseal Fractures of Humerus
Diaphyseal Fractures of the Humerus: A Prospective Cohort Study Comparing the Conservative Treatment and the Surgical Treatment.
The fracture of the humeral diaphysis is a condition that represents 2% of all fractures. The conservative treatment of diaphyseal fractures of the humerus has long been considered the only option and the surgical treatment was primarily reserved for displaced fractures with no contact of bone ends. However, for a few years there has been an upsurge of indications for the surgical treatment of diaphyseal fractures.
The purpose of this study is to compare the functional outcomes and the quality of life of surgically treated patients versus those who undergo a conservative treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Quebec, Canada, G1J 1Z4
- Hopital L'Enfant-Jesus
-
-
Quebec
-
Québec, Quebec, Canada, G1J 1Z4
- CHA-Pavillon Enfant-Jésus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female over 18 years
- Fracture of the humeral diaphysis
- Recent fracture (14 days or less)
- Closed fracture
- Signing of consent form
Exclusion Criteria:
- Segmental fracture of the humerus
- Fracture with proximal or distal intra articular extension
- Open fracture
- Polytrauma
- Floating elbow or shoulder
- Pathological fracture
- Simultaneous fracture of both humerus
- Associated vascular disease
- Severe neuromuscular disorders such as Parkinson, hemiparesis, myasthenia gravis, muscular dystrophy, etc. ...
- medical contraindication to surgery
- severe central neurological disease disabling patient to fill in questionnaires (senile dementia, Alzheimer's, etc ...
- Male or female unable to consent
- Any other condition which prevents the assessor from fully monitoring the patient during study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Surgical treatment
Patients included in the surgical group will have surgery to treat the fracture.
|
Patients included in the surgical group will be divided into two subgroups according to the method of fixation chosen: plate and screws or nailing.
Surgeries take place under general anesthesia and a prophylaxis antibiotic is administrated.
The installation and the approach will be chosen by the surgeon according to his preferences.
A thoraco brachial brace is placed on the patient at the end of the intervention and it remains in place for a period of 5 to 10 days (patient comfort).
A gradual mobilization of the elbow and shoulder will be initiated by the patient at home.
The addition of physical therapy will be decided by the surgeon and noted down accordingly.
|
|
Active Comparator: Conservative treatment group
Patients included in the conservative group will be taken to a plaster room where a Hanging Support System(HSS) brace will be installed by a qualified technician.
|
Patients included in the conservative group will be taken to a plaster room where the HSS brace will be installed by a qualified technician.
Advice will be provided for the care, personal hygiene and clothing.
The brace will be kept for a period of 6 to 12 weeks depending on the degree of healing of fracture.
The maintenance of the proximal part (Brace) may be recommended by the surgeon.
The mobilization will begin with exercises at home and whether the patient does physical therapy or not is the surgeon's choice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Function and quality of life on DASH scale
Time Frame: 6 months after treatment
|
The function and quality of life are measured using the DASH scale six months after treatment.
|
6 months after treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DASH score
Time Frame: 6 months after treatment
|
The function and quality of life are measured using the DASH scale 6 months after treatment.
|
6 months after treatment
|
|
Return to professional activities
Time Frame: 3 months after treatment
|
It will be determined in days after surgery, to rates of 50% and 100% of the usual workload.
|
3 months after treatment
|
|
SF-36 score
Time Frame: 6 months after treatment
|
This score will help validate the impact on quality of life of both types of treatment.
It includes 36 items asking about the recent quality of life.
This will also enable better understanding of the impact in real time on the functional level.
|
6 months after treatment
|
|
DASH score
Time Frame: 12 months after treatment
|
The function and quality of life are measured using the DASH scale 12 months after treatment.
|
12 months after treatment
|
|
SF-36 score
Time Frame: 12 months after treatment
|
This score will help validate the impact on quality of life of both types of treatment.
It includes 36 items asking about the recent quality of life.
This will also enable better understanding of the impact in real time on the functional level.
|
12 months after treatment
|
|
Proportion of additional surgeries
Time Frame: 12 months after surgery
|
The evaluation of the rate of complications such as infection, implant removal, non-union, implant failure or malunion which necessitate additional surgery.
|
12 months after surgery
|
|
Radiological loss of reduction
Time Frame: 2 weeks after treatment
|
The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion. We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels. |
2 weeks after treatment
|
|
Radiological loss of reduction
Time Frame: 6 weeks after treatment
|
The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion. We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels. |
6 weeks after treatment
|
|
Radiological loss of reduction
Time Frame: 12 weeks after treatment
|
The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion. We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels. |
12 weeks after treatment
|
|
Radiological loss of reduction
Time Frame: 6 months after treatment
|
The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion. We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels. |
6 months after treatment
|
|
Union rate
Time Frame: 12 weeks after treatment
|
The union is defined by the presence of a strong radiological callus associated with lack of pain at the fracture site. The humerus unifies in an average of three months. It is considered non-union if it is not unified after six months, and it is classified as delayed union between 3 and 6 months. The rates will be presented by the number of patients with non-union in each group. |
12 weeks after treatment
|
|
Union rate
Time Frame: 6 months after treatment
|
The union is defined by the presence of a strong radiological callus associated with lack of pain at the fracture site. The humerus unifies in an average of three months. It is considered non-union if it is not unified after six months, and it is classified as delayed union between 3 and 6 months. The rates will be presented by the number of patients with non-union in each group. |
6 months after treatment
|
|
Rates of complication
Time Frame: within the first year following treatment
|
The main complications recognized in the treatment of humerus fractures are: infection, nerve damage, malunion and non-unions.
Each complication will be recorded and reported.
|
within the first year following treatment
|
|
Pain on visual analogue pain scale (VAS)
Time Frame: 2 weeks after treatment
|
The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.
|
2 weeks after treatment
|
|
Pain on VAS
Time Frame: 6 weeks after treatment
|
The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.
|
6 weeks after treatment
|
|
Pain on VAS
Time Frame: 12 weeks after treatment
|
The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.
|
12 weeks after treatment
|
|
Pain on VAS
Time Frame: 6 months after treatment
|
The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.
|
6 months after treatment
|
|
Pain on VAS
Time Frame: 12 months after treatment
|
The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.
|
12 months after treatment
|
|
Measurement of range of motion of the shoulder
Time Frame: 2 weeks after treatment
|
Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).
|
2 weeks after treatment
|
|
Measurement of range of motion of the shoulder
Time Frame: 6 weeks after treatment
|
Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).
|
6 weeks after treatment
|
|
Measurement of range of motion of the shoulder
Time Frame: 12 weeks after treatment
|
Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).
|
12 weeks after treatment
|
|
Measurement of range of motion of the shoulder
Time Frame: 6 months after treatment
|
Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).
|
6 months after treatment
|
|
Measurement of range of motion of the shoulder
Time Frame: 12 months after treatment
|
Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).
|
12 months after treatment
|
|
Measurement of range of motion of the elbow
Time Frame: 2 weeks after treatment
|
Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).
|
2 weeks after treatment
|
|
Measurement of range of motion of the elbow
Time Frame: 6 weeks after treatment
|
Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).
|
6 weeks after treatment
|
|
Measurement of range of motion of the elbow
Time Frame: 12 weeks after treatment
|
Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).
|
12 weeks after treatment
|
|
Measurement of range of motion of the elbow
Time Frame: 6 months after treatment
|
Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).
|
6 months after treatment
|
|
Measurement of range of motion of the elbow
Time Frame: 12 months after treatment
|
Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).
|
12 months after treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stéphane Pelet, MD, PhD, Hôpital de l'Enfant-Jésus
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEJ-530
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Humeral Diaphysis Fracture
-
University Hospital, Clermont-FerrandCompletedHumeral Diaphysis Fracture | Humeral Upper Extremity FractureFrance
-
University of Southern DenmarkRegion of Southern DenmarkActive, not recruitingProximal Humeral Fracture | Humeral Head FractureDenmark
-
University of HelsinkiFinnish Institute for Health and WelfareTerminated
-
University Hospital, LinkoepingCompletedHumeral FractureSweden
-
University of HelsinkiHelsinki University Central Hospital; Finnish Institute for Health and WelfareTerminated
-
Hacettepe UniversityUnknown
-
Ain Shams UniversityCompletedProximal Humeral FracturesEgypt
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedHumeral Fracture, Proximal
-
Karolinska InstitutetCompleted
-
Herlev HospitalOdense University Hospital; Zealand University Hospital; Aalborg University HospitalUnknownProximal Humeral FracturesDenmark
Clinical Trials on Plate and screws or nailing
-
Ankara UniversityRecruitingMetastatic Cancer | Bone Metastases | Pathologic FractureTurkey
-
University of CincinnatiRecruitingAcetabular FractureUnited States
-
Joseph Van SickelsCompleted
-
Assiut UniversityNot yet recruitingGreater Tuberosity FractureEgypt
-
Sohag UniversityRecruitingFracture of Pediatric Neck FemurEgypt
-
Prisma Health-UpstateIndiana University; Orthopaedic Trauma AssociationCompletedHigh Energy Midshaft Clavicle FracturesUnited States
-
AO Clinical Investigation and Publishing DocumentationTerminatedClinical Indication for First Metatarsal Joint ArthrodesisUnited States, Colombia, United Kingdom
-
Isfahan University of Medical SciencesCompletedTibial Shaft FractureIran, Islamic Republic of
-
Oslo University HospitalVestre Viken Hospital Trust; Ostfold Hospital TrustActive, not recruiting